ArticleMolecular therapy oncolytics2022

LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway.

Weitao Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.